UP FINTECH HOLDING LIMITED (TIGR) Spending and interest coverage
- R&D / revenue · 12 months: Value 16.34%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 16.34% | Research and development expense / revenue. Period ending 2025-12-31. $100.01M ÷ $612.06M × 100 ≈ 16.34% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 100.01M USD | Research and Development Expense |
| Revenue | 612.06M USD | |
| Stock-based compensation | (m) | |
| Operating income | (m) | |
| Interest expense · reported / estimated | 73.36M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $100.01M | $612.06M | (m) | (m) | $73.36M | 16.34% | (m) | (m) | Reported |
| 2024-12-31 | $80.13M | $391.54M | (m) | (m) | $60.80M | 20.46% | (m) | (m) | Reported |
| 2024-06-30 | (m) | $306.51M | (m) | (m) | $56.50M | (m) | (m) | (m) | Reported |
| 2023-12-31 | $63.46M | $272.51M | (m) | (m) | $46.96M | 23.29% | (m) | (m) | Reported |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $60.15M | $225.37M | (m) | (m) | $18.67M | 26.69% | (m) | (m) | Reported |
| 2021-12-31 | $47.77M | $264.49M | (m) | (m) | $18.38M | 18.06% | (m) | (m) | Reported |
| 2020-12-31 | $22.51M | $138.50M | (m) | (m) | $10.10M | 16.25% | (m) | (m) | Reported |
| 2019-12-31 | $18.03M | $58.66M | (m) | (m) | $4.10M | 30.74% | (m) | (m) | Reported |
| 2018-12-31 | $11.28M | $33.56M | (m) | (m) | (m) | 33.62% | (m) | (m) | (m) |
| 2017-12-31 | $6.06M | $16.95M | (m) | (m) | (m) | 35.75% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.